Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

MRI may sharpen Watch-and-Wait for prostate cancer

NCT ID NCT03648359

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: Herlev Hospital Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 27 times

Summary

This study looks at whether a special MRI scan (multiparametric MRI) can better identify which men with low-risk prostate cancer can safely avoid immediate treatment and just be monitored (active surveillance). About 200 men already on active surveillance will get the MRI. If the scan finds suspicious areas, doctors will check them with a biopsy to see if treatment is needed. The goal is to improve monitoring and reduce unnecessary procedures.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Department of Urology, Herlev University Hospital Herlev

    Herlev, 2730, Denmark

Conditions

Explore the condition pages connected to this study.